Loss in McL-1 Function Sensitizes Non-Hodgkin’s Lymphoma Cell Lines to the BCL-2-selective Inhibitor Venetoclax (ABT-199)
Blood Cancer Journal - United States
doi 10.1038/bcj.2015.88
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Springer Science and Business Media LLC